Federal Court Blocks Colorado's Amgen Drug Price Cap

A federal judge paused Colorado's first-ever state-imposed price cap on Amgen's blockbuster arthritis drug, Enbrel. This ruling follows a lawsuit filed by Amgen, arguing the state panel lacked the authority to set prices. It means consumers in Colorado will continue to pay the current market price for Enbrel, rather than the state-mandated lower price.